Patients with stage IV ovarian cancer can derive long-term benefits from neoadjuvant pembrolizumab and chemotherapy if they achieve a major pathologic response, according to research published in ...

A new FDA application for relacorilant shows promising survival benefits in treating platinum-resistant ovarian cancer, ...

Ovarian Cancer Drugs Market grows as FDA, EMA fast-track advanced-stage therapies, boosting global approvals and innovation. Anurag Tiwari Orion Market Research Pvt Ltd + +91 91798 28694 email us here ...

Non-Small Cell Lung Cancer Market grows as immunotherapy approvals by Merck & Bristol-Myers reshape global treatment pathways. Anurag Tiwari Orion Market Research Pvt Ltd +91 91798 28694 email us here ...

An unusual DNA structure may hold the key to treating one of the deadliest cancers affecting women, which claims more than ...

New preclinical research shows a promising drug combination that targets ovarian cancer’s survival pathways, paving the way ...

After ovarian cancer surgery, Mary Barbera spent three months in rehab before finally returning home, a milestone that marked ...

Chemotherapy used to target and kill bladder cancer cells may trigger an inflammatory response that ultimately may make the cancer more resistant to treatment, according to new research from ...

The response rate was higher in those with a KRAS mutation at 44%, compared to 17% in KRAS wild-type patients.